PROFILPELAJAR.COM

Ofornine

Ofornine
Clinical data
Other namesWin 48049
Identifiers
  • 1-Piperidinyl(2-(4-pyridinylamino)phenyl)methanone
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.081.195 Edit this at Wikidata
Chemical and physical data
FormulaC17H19N3O
Molar mass281.359 g·mol−1
3D model (JSmol)
  • C1CCN(CC1)C(=O)C2=CC=CC=C2NC3=CC=NC=C3
  • InChI=1S/C17H19N3O/c21-17(20-12-4-1-5-13-20)15-6-2-3-7-16(15)19-14-8-10-18-11-9-14/h2-3,6-11H,1,4-5,12-13H2,(H,18,19)
  • Key:YMODINPJYNHPTM-UHFFFAOYSA-N

Ofornine is a synthetic compound investigated primarily for its antihypertensive properties. It functions as a vasodilator and exhibits presynaptic adrenolytic activity, with evidence suggesting involvement of dopaminergic mechanisms in its pharmacological effects.[1]

A number of structural analogs have been prepared with similar activity.[2]

Chemistry

Ofornine contains a pyridine moiety,[3] or more specifically a fampridine or anthranilamide (c.f. fenamate).

Synthesis

Synthesis:[4][5] Patent:[6]

Reaction between 4-chloropyridine [626-61-9] HCl: [7379-35-3] (1) and anthranilic acid [118-92-3] (2) gives 2-(4-pyridylamino)benzoic acid [34861-30-8] (3). Halogenation with thionyl chloride gave 2-(4-pyridinylamino)-benzoyl chloride [89989-83-3] (4). Amide formation with piperidine [110-89-4] (5) completed the synthesis of Ofornine (6).

References

  1. ^ Defelice A, Lape H, Horan P, Frering R, Brousseau A, O'Connor B, et al. (January 1990). "Antihypertensive, vasodilating, and sympatholytic activities of ofornine® in spontaneously hypertensive rats". Drug Development Research. 20 (3): 277–290. doi:10.1002/ddr.430200303.
  2. ^ Mushtaq A, Rayees S, Rouf A, Kumar B, Sharma A, Nagaraju PV, et al. (February 2017). "Synthesis of Ofornine mimics from natural product l-vasicine as anti-hypertensive agents". Bioorganic & Medicinal Chemistry. 25 (4): 1440–1447. doi:10.1016/j.bmc.2017.01.006. PMID 28110819.
  3. ^ Lukevits E (June 1995). "Pyridine derivatives in the drug arsenal (150 years of pyridine chemistry)". Chemistry of Heterocyclic Compounds. 31 (6): 639–650. doi:10.1007/BF01169065.
  4. ^ Lednicer D, Mitscher LA (1990). The organic chemistry of drug synthesis. Vol. 4. Wiley. ISBN 978-0-471-85548-4.
  5. ^ Wang H, Wei G (2023). Ganesapillai M, Abdullah AZ (eds.). "Introduction to Retrosynthesis: Strategies and Approaches". E3S Web of Conferences. 385: 04008. Bibcode:2023E3SWC.38504008W. doi:10.1051/e3sconf/202338504008. ISSN 2267-1242.
  6. ^ US 4610991, Bailey DM, "Antihypertensive pyridylaminobenzamide compounds", issued 9 September 1986, assigned to Sterling Drug Inc. 

Content Disclaimer

Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.

  1. The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
  2. There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
  3. It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
  4. Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
  5. Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.